Guess What China did Prior to COVID-19 "Outbreak" ?

A new law that was conveniently passed in China on June 29, 2019, a few months before Event 201 and the coronavirus outbreak, mandated obligatory vaccination for all citizens of China. The government would also like to electronically track vaccine records, and it makes you wonder how Bill Gates will play into this. The law would take effect on December 1, 2019, after which cases of pneumonia (COVID-19) starting taking place. The question we must now ask ourselves is: what vaccines were reportedly being used before the spike of coronavirus cases? It seems awfully suspicious, but more research is needed. If you are not familiar with how viral agents (found in vaccines) can mimic the symptoms of a disease, mutate, and be detected in subsequent viral screening, it is recommended that you hear some lectures by Dr. Tent.

China: Strict Mandatory Vaccine Law Came Into Affect Just Weeks Before COVID-19 Outbreak

(Aug. 27, 2019) - On June 29, 2019, the National People’s Congress Standing Committee of the People’s Republic of China (PRC or China) adopted the PRC Law on Vaccine Administration (Vaccine Law). The official Xinhua news agency states that the Law provides for the “strictest” vaccine management with tough penalties ...

Before the passage of this 100-article Law, provisions governing vaccines were contained in the PRC Drug Administration Law, PRC Law on the Prevention and Treatment of Infectious Diseases, and a few relevant administrative regulations and rules.

The new Law provides for regulatory requirements for researching, producing, distributing, and using vaccines. Such requirements, according to one legal commentator, are much more stringent than those for other drugs (art. 2). It also contains a chapter specifying penalties for violating the Vaccine Law, which are also stricter than those for violating other drug laws (ch. 10). According to the Law, if any violation of this Law constitutes a crime, a “heavier punishment” within the range of punishments provided by the Criminal Law on the relevant crimes is to be imposed (art. 79).

The Law mandates the launching of a national vaccine electronic tracking platform that integrates tracking information throughout the whole process of vaccine production, distribution, and use to ensure all vaccine products can be tracked and verified (art. 10).

According to the Law, China is to implement a state immunization program, and residents living within the territory of China are legally obligated to be vaccinated with immunization program vaccines, which are provided by the government free of charge. Local governments and parents or other guardians of children must ensure that children be vaccinated with the immunization program vaccines (art. 6).

The Law establishes a compensation system for abnormal reactions to vaccination. A recipient of an immunization program vaccine who dies or suffers significant disability or organ and tissue damage is to be paid from the vaccination funds of the provincial level government if the damage falls within the scope of abnormal reactions associated with a vaccine or cannot be prevented (art. 56).

The Law will take effect on December 1, 2019 (art. 100).

Vaccine Hesitancy in China

What is interesting is that BMC Public Health (China's Social Capital Health) conducted a study in November 2019, titled Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study: 

A majority of the respondents held negative attitudes towards vaccines after the Changsheng vaccine incident. A coordinated effort is required to restore public confidence in vaccines, especially in China, where a nationwide mandatory immunization policy is implemented. To end dissent towards inoculation, a series of actions is crucial and multiple parties should work together to advance efforts and explore the possibility of establishing an open and transparent regulatory system.

US Vaccine Companies Benefit from China's Purchases

You can be sure that the media will be used to restore the image of vaccine companies and government vaccine programs. There is another similar study on vaccine hesitancy in China, that can be read here.  

In Precision Vaccinations, we're told: 

‘China's vaccine market will have a rosy prospect.’ ... ‘The growing demand for vaccines comes with a large population base, the aging of the population, and more than 15 million newborns each year,’ said this press release...To meet this increased consumer demand, Chinese vaccine companies are now competing with foreign firms on new vaccines, such as the 13-valent pneumococcal vaccine and HPV vaccine.

Walvax Biotechnology's 13-valent pneumococcal vaccine has been applied for certification and is expected to be the first approved homemade vaccine of such kind in China...Also, Beijing Wantai Biological Pharmacy Enterprise's 2-valent HPV vaccine is expected to be the first approved homemade vaccine of its class in China. 

Pneumonia Vaccines Administered in January

Even more odd, is that during the US China trade war and tensions, China has chosen to use a US vaccine. It was reported on Jan 2, 2020 that: 

The National Medical Products Administration (NMPA) has given the go-ahead for the launch of China's first self-developed 13-valent pneumonia vaccine [to be used for babies and children] ...  from the invasive pneumococcal disease caused by 13 serotypes...The only 13-valent pneumonia vaccine available in today's global market is manufactured by U.S. biopharmaceutical company Pfizer. In 2016, the product won approval to enter the Chinese market.

We are also told on Jan 2, 2020:

Pfizer’s Prevnar 13 and Merck & Co.’s HPV franchise Gardasil are the world’s best-selling vaccines, and China sales have been driving growth for both of them ... And the Pfizer product has been selling up a storm in China. After an approval in late 2016 and an official launch the next year, China soon injected new life into the Pfizer stalwart, sold as Prevenar 13 in the country ...A ccording to data from China’s National Institutes for Food and Drug Control—which is responsible for testing vaccine batches before release—about 8.7 million HPV shots were waved through in 2019 as of November.

COVID-19 Vaccine Trials Begin

Meanwhile, China starts trials for COVID-19 vaccine, actively funded by the medical military:

The trial is designed to enrol 108 volunteers aged 18-60 years who are residents of Wuhan... The experimental candidate is a recombination vaccine developed by biotechnology company CanSino Biologics in alliance with a research team from the PLA Academy of Military Medical Sciences ... Last week, CanSino Biologics received regulatory approval to conduct a Phase I trial of its recombinant novel coronavirus vaccine (adenovirus type 5 vector) candidate.  

COVID-19 is a respiratory virus which causes symptoms of pneumonia. 

Bill Gates Funds Millions for Electronic Tracking of Vaccine Records